Roquefort Therapeutics plc / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €230.47K +∞% -€2.01M +8.0% -872.3% -8.7 pp -€1.94M +6.5% -839.7% -8.4 pp
    €0.00 -100.0% -€1.86M +76.1% N/A -€1.82M -39.9% N/A
    €828.53 -€1.06M -127,598.5% -€3.02M -364,817.1%

    Notifications